VISTAGEN THERAPEUTICS, INC. — Revenue by Fiscal Year
14 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/6b4f049e-45ea-482e-9a2a-c754fdd09f98/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $1.3M | 2025-04-01 – 2026-03-31 | evidence 0001628280-26-043271 |
| FY 2024 | $486.0k | 2024-04-01 – 2025-03-31 | evidence 0001411685-25-000041 |
| FY 2023 | $1.1M | 2023-04-01 – 2024-03-31 | evidence 0001411685-24-000022 |
| FY 2022 | $-227.0k | 2022-04-01 – 2023-03-31 | evidence 0001437749-23-018793 |
| FY 2021 | $1.1M | 2021-04-01 – 2022-03-31 | evidence 0001851734-22-000349 |
| FY 2020 | $1.1M | 2020-04-01 – 2021-03-31 | evidence 0001851734-22-000349 |
| FY 2019 | $0 | 2019-04-01 – 2020-03-31 | evidence 0001654954-21-007380 |
| FY 2017 | $0 | 2017-04-01 – 2018-03-31 | evidence 0001654954-18-006990 |
| FY 2016 | $1.2M | 2016-04-01 – 2017-03-31 | evidence 0001654954-17-005976 |
| FY 2015 | $0 | 2015-04-01 – 2016-03-31 | evidence 0001654954-17-005976 |
| FY 2013 | $16.4M | 1998-11-26 – 2014-03-31 | evidence 0001415889-14-001957 |
| FY 2012 | $200.4k | 2012-04-01 – 2013-03-31 | evidence 0001415889-13-001409 |
| FY 2011 | $16.2M | 1998-05-26 – 2012-03-31 | evidence 0001415889-12-000973 |
| FY 2010 | $2.1M | 2010-04-01 – 2011-03-31 | evidence 0001415889-12-000973 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
VISTAGEN THERAPEUTICS, INC. — all facts · Net Income · Operating Income